Literature DB >> 19683073

Surgery for gastroesophageal reflux disease: esophageal impedance to progress?

Stuart Jon Spechler.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19683073      PMCID： PMC2789853          DOI： 10.1016/j.cgh.2009.08.003

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  10 in total

1.  Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids.

Authors:  J Theisen; D Nehra; D Citron; J Johansson; J A Hagen; P F Crookes; S R DeMeester; C G Bremner; T R DeMeester; J H Peters
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

Review 2.  Is there a dark side to long-term proton pump inhibitor therapy?

Authors:  Thomas B Nealis; Colin W Howden
Journal:  Am J Ther       Date:  2008 Nov-Dec       Impact factor: 2.688

3.  Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis.

Authors:  N Chiba; C J De Gara; J M Wilkinson; R H Hunt
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

4.  Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.

Authors:  I Mainie; R Tutuian; A Agrawal; D Adams; D O Castell
Journal:  Br J Surg       Date:  2006-12       Impact factor: 6.939

5.  The role of esophageal pH monitoring in symptomatic patients on PPI therapy.

Authors:  Samer Charbel; Farah Khandwala; Michael F Vaezi
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

6.  Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study.

Authors:  Thomas Tran; Stuart J Spechler; Peter Richardson; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2005-05       Impact factor: 10.864

7.  Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.

Authors:  Donald O Castell; Peter J Kahrilas; Joel E Richter; Nimish B Vakil; David A Johnson; Seth Zuckerman; Wendy Skammer; Jeffrey G Levine
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

8.  Gastric and esophageal pH in patients with Barrett's esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial.

Authors:  Stuart J Spechler; Prateek Sharma; Barry Traxler; Douglas Levine; Gary W Falk
Journal:  Am J Gastroenterol       Date:  2006-07-18       Impact factor: 10.864

Review 9.  Meta-analysis of randomized clinical trials comparing open and laparoscopic anti-reflux surgery.

Authors:  Matthew James Peters; Athar Mukhtar; Rossita Mohamad Yunus; Shahjahan Khan; Juanita Pappalardo; Breda Memon; Muhammed Ashraf Memon
Journal:  Am J Gastroenterol       Date:  2009-04-28       Impact factor: 10.864

10.  Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.

Authors:  I Mainie; R Tutuian; S Shay; M Vela; X Zhang; D Sifrim; D O Castell
Journal:  Gut       Date:  2006-03-23       Impact factor: 23.059
  10 in total
  9 in total

1.  Image-enhanced endoscopy is specific for the diagnosis of non-erosive gastroesophageal reflux disease.

Authors:  Neil D Parikh; Artur V Viana; Saloni Shah; Loren Laine
Journal:  Scand J Gastroenterol       Date:  2018-01-25       Impact factor: 2.423

2.  Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring.

Authors:  Marzio Frazzoni; Rita Conigliaro; Gianluigi Melotti
Journal:  Dig Dis Sci       Date:  2010-08-25       Impact factor: 3.199

3.  Postoperative impedance-pH testing is unreliable after Nissen fundoplication with or without giant hiatal hernia repair.

Authors:  Brittany N Arnold; Christy M Dunst; Angi B Gill; Trudie A Goers; Lee L Swanström
Journal:  J Gastrointest Surg       Date:  2011-06-30       Impact factor: 3.452

4.  Conventional versus robot-assisted laparoscopic Nissen fundoplication: a comparison of postoperative acid reflux parameters.

Authors:  Marzio Frazzoni; Rita Conigliaro; Giovanni Colli; Gianluigi Melotti
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

Review 5.  ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

Authors:  Philip O Katz; Kerry B Dunbar; Felice H Schnoll-Sussman; Katarina B Greer; Rena Yadlapati; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2022-01-01       Impact factor: 10.864

6.  Acid burn or cytokine sizzle in the pathogenesis of heartburn?

Authors:  Xiaofang Huo; Rhonda F Souza
Journal:  J Gastroenterol Hepatol       Date:  2013-03       Impact factor: 4.029

7.  Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease.

Authors:  Reginald C W Bell; Katherine D Freeman
Journal:  Surg Endosc       Date:  2010-12-08       Impact factor: 4.584

Review 8.  Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?

Authors:  Barbara Ruaro; Riccardo Pozzan; Paola Confalonieri; Stefano Tavano; Michael Hughes; Marco Matucci Cerinic; Elisa Baratella; Elisabetta Zanatta; Selene Lerda; Pietro Geri; Marco Confalonieri; Francesco Salton
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-22

9.  Regurgitation in healthy and non healthy infants.

Authors:  Flavia Indrio; Giuseppe Riezzo; Francesco Raimondi; Luciano Cavallo; Ruggiero Francavilla
Journal:  Ital J Pediatr       Date:  2009-12-09       Impact factor: 2.638
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.